Regulus Therapeutics Inc. (RGLS): 3 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jun 4, 2025 | Klassen Preston Director, Officer | 12,000 | $7.99 | $95.9K | no history |
| Jan 31, 2025 | Baltimore David Director | 19,610 | $1.06 | $20.8K | no history |
| Jan 31, 2025 | Hagan Joseph P Director, Officer | 50,000 | $1.09 | $54.5K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.